Universal Health Services (UHS) Morgan Stanley 24th Annual Global Healthcare Conference summary

Financial performance and guidance

• Q2 results showed rebounding volumes and strong cost control, with a benefit from the Florida DPP program recognized for 2025.

• Guidance was revised downward by $50 million due to unfavorable items, now projecting 3% EBITDA less NCI growth and 6% EPS growth for the year.

• Closed the Talkspace acquisition and executed a $1.1 billion bond deal, securing financing for several years.

• Acute care volume projections for the year were lowered slightly, now expecting 1.5%-2.5% growth, consistent with historical trends.

• Exchange patient headwinds are expected to total $85-$90 million this year, with the largest impact anticipated in 2026.

Behavioral health strategy and growth

• Outpatient behavioral health is the main growth opportunity, with volume guidance at 1%-2% and pricing at 2%-3%.

• The Talkspace acquisition adds 6,000 therapists and expands outpatient and virtual care capacity.

• Outpatient revenue is less Medicaid-centric, shifting payer mix toward Medicare and commercial payers.

• The Thousand Branches initiative is expanding freestanding outpatient behavioral facilities, with 15 open and plans for 10 more annually.

• Integration of inpatient, outpatient, and virtual care creates a seamless continuum for patients.

Acute care operations and expansion

• Recent hospital openings include West Henderson (profitable in its first quarter), Cedar Hill (slower ramp-up but breaking even by Q4), and Alan B. Miller Medical Center (expected to reach average margins in 18-36 months).

• Freestanding emergency departments (35 nationwide) and ambulatory surgery centers are key outpatient access points.

• Surgical volumes are softer in low-acuity areas but growing in high-acuity specialties like cardiology and neurology.

• CapEx will decrease as no new large de novo hospital projects are planned, increasing flexibility for share repurchases.